Merck, Patient Seek Separate JMOL In Fosamax Trial

Law360, New York (September 1, 2009, 1:23 PM EDT) -- Pharmaceutical giant Merck & Co. Inc. has asked a federal judge to dismiss the remaining claims in a product liability and personal injury case over its osteoporosis drug Fosamax, while the consumer who claims that Fosamax caused her to develop a degenerative bone disease has moved for partial judgment on several of Merck's affirmative defenses.

Merck filed its amended motion for judgment as a matter of law Tuesday, and plaintiff Shirley Boles requested a partial JMOL Monday from Judge John F. Keenan in the U.S. District...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.